Locations
Oxford, UK · Oxfordshire, UK · England, UK
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2019
Ochre Bio is a pioneering biotechnology company focused on developing RNA therapies to address chronic liver diseases. Utilizing advanced genomic and multi-omic technologies, the company generates extensive genomic and phenotypic data from human models to create innovative treatments. Their unique approach allows for rapid progression from target identification to validated lead development, significantly reducing the time required for clinical success. With a commitment to addressing the rising global challenge of liver disease, Ochre Bio is positioned at the forefront of liver health innovation, backed by a team of leading experts in genomics and drug discovery.
Something looks off?On-site & Remote